pharma · Advanced Solid Tumor · Hepatocellular Carcinoma
Coherus Oncology
Coherus Oncology clinical programs — 9 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- 333 Twin Dolphin Drive, Suite 600, Redwood City, CA 94065, US
- Founded
- 2010
- Employees
- 212
- Programs
- 25
- Drugs
- 11
- Patents
- 73
Coherus Oncology projects
9 ClinicalTrials.gov programs sponsored by Coherus Oncology.
Coherus Oncology has 9 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
CHS-006 (anti-TIGIT)
Coherus Oncology
Advanced Solid Tumor
1 trial -
CHS-1000
Coherus Oncology
Advanced or Metastatic Solid Tumors
1 trial -
CHS-114
Coherus Oncology
Advanced Solid Tumor
1 trial -
CHS-114
Coherus Oncology
Metastatic Solid Tumor
1 trial -
CHS-1701
Coherus Oncology
Bioequivalence
1 trial -
CHS-1701
Coherus Oncology
Healthy
1 trial -
CHS-1701
Coherus Oncology
Immunity, Humoral
1 trial -
CHS-388
Coherus Oncology
Advanced Solid Tumor
1 trial -
SRF617
Coherus Oncology
Advanced Solid Tumor
1 trial
Frequently asked questions
How many clinical projects does Coherus Oncology have?
9 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.